Brand-Generic Patent Settlements Reported to the US Federal Trade Commission

C. Joseph Ross Daval, Alexander C. Egilman, Aaron S. Kesselheim

Open source

DOI: 10.1001/jamahealthforum.2026.4009
Published: 2026-11-06
Container: JAMA Health Forum
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamahealthforum.2026.4009,
  title = {Brand-Generic Patent Settlements Reported to the US Federal Trade Commission},
  author = {C. Joseph Ross Daval and Alexander C. Egilman and Aaron S. Kesselheim},
  year = {2026},
  journal = {JAMA Health Forum},
  doi = {10.1001/jamahealthforum.2026.4009},
  url = {https://doi.org/10.1001/jamahealthforum.2026.4009}
}

RIS

TY  - JOUR
TI  - Brand-Generic Patent Settlements Reported to the US Federal Trade Commission
AU  - C. Joseph Ross Daval
AU  - Alexander C. Egilman
AU  - Aaron S. Kesselheim
PY  - 2026
JO  - JAMA Health Forum
DO  - 10.1001/jamahealthforum.2026.4009
UR  - https://doi.org/10.1001/jamahealthforum.2026.4009
ER  -

APA

Daval, C. J. R., Egilman, A. C., & Kesselheim, A. S. (2026). Brand-Generic Patent Settlements Reported to the US Federal Trade Commission. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2026.4009

Source records

crossref · retrieved 2026-11-08T12:37:45.158Z